Skip to main content
Rheumatology (Oxford, England) logoLink to Rheumatology (Oxford, England)
. 2022 Dec 13;62(5):2021. doi: 10.1093/rheumatology/keac686

Correction to: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

PMCID: PMC10152275  PMID: 36511437

This is a correction to: Mark D Russell, Mrinalini Dey, Julia Flint, Philippa Davie, Alexander Allen, Amy Crossley, Margreta Frishman, Mary Gayed, Kenneth Hodson, Munther Khamashta, Louise Moore, Sonia Panchal, Madeleine Piper, Clare Reid, Katherine Saxby, Karen Schreiber, Naz Senvar, Sofia Tosounidou, Maud van de Venne, Louise Warburton, David Williams, Chee-Seng Yee, Caroline Gordon, Ian Giles, BSR Standards, Audit and Guidelines Working Group, British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids, Rheumatology, 2022, https://doi.org/10.1093/rheumatology/keac551

In the originally published version of this manuscript, table 2 contained an error: it erroneously referred to “foetus acid” instead of “folic acid.”

This error has now been corrected.


Articles from Rheumatology (Oxford, England) are provided here courtesy of Oxford University Press

RESOURCES